News

The President of the Republic of Bulgaria bestowed the “Excellence in Innovation” Award on Comac Medical

The President of the Republic of Bulgaria Rumen Radev delivered the prestigious mark “Excellence in Innovation” to the owner and CEO of Comac Medical Dr. Milen Vrabevski as a finalist in the “Innovative Enterprise of the Year” competition for 2016, 2017 and 2018. The award is given for the first time for high quality and originality of the innovations of the Bulgarian companies, their impact on the national and world market, on the environment and the society, for the efficiency of the business model.

Comac Medical received the prestigious award for the development of a hi-tech, integrated system for collecting, managing and analyzing clinical data. The innovation enables greater accuracy and precision in relevant analyzes and studies within the framework of ongoing clinical trials.

This is not the first prize of such kind for Comac Medical. In 2016, the company was nominated for “Most Innovative Enterprise”. In its detailed IMP³rove Benchmarking report for assessment of the innovative potential of the companies in Europe, the European Commission placed Comac Medical among the so-called Growth Champions, awarding it with its Seal of Excellence. In addition, Comac Medical placed Bulgaria on the map of Horizon 2020 with an innovative approach to early diagnosis of inflammatory and degenerative lung processes such as asthma, COPD, tuberculosis, lung cancer, etc.

The brand “Excellence in Innovation” is given to the finalists in the “Innovative Enterprise of the Year” competition. It is organized by the Applied Research and Communications Foundation and Enterprise Europe Network – Bulgaria and under the patronage of the President of the Republic of Bulgaria Rumen Radev.

ExcellenseInInnovation_CM

 

Share:
Before the Lab: Roots & Dreams My name is Brisilda Pashaj, I am 29 years old, and I...
Planning a clinical trial comes with numerous challenges, requiring a methodical approach for successful execution. However, unforeseen issues...
Abstract: In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120...